CALIXAR will attend the digital 9th Antibody Industrial Symposium 2021 on June 22 - 25, 2021

June 10, 2021

CALIXAR team will be present at the online 9th Antibody Industrial Symposium 2021, from June 22 to 25, 2021 to discuss about commercial and scientific opportunities linked to our activities.

CALIXAR is a biotech company specialized in the identification and isolation of functional membrane therapeutic targets and antigens (GPCRs, Ion channels, Transporters, …). The company is currently investing in the extension of its pipeline of highly druggable membrane protein targets and native antigens. Within the next few years, CALIXAR will be able to offer to Pharma companies native and functional therapeutic targets validated and in a ready-to-discovery format.

The biotech company wants to become a leader in the early discovery segment of drug development based on complex therapeutic targets (membrane proteins), a market predicted to be worth € 70 bn by 2025.

About 9th Antibody Industrial Symposium

The 9th Antibody Industrial Symposium is an international congress jointly organized by the scientific society LabEx MAbImprove and the industrial organization MabDesign. It is part of the series of Industrial Symposia organized by MAbImprove since 2013. The AIS2021 is the ideal conference for scientists, industrials, physicians and policymakers to exchange about therapeutic antibodies and more! The Scientific committee has set up an exciting program, with keynote lectures, pitch talks around new creative projects, and industrial talks from big pharmaceutical companies.

For more information and meet us: 9th Antibody Industrial Symposium

Share this post

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.